JAK/STAT signal transduction: Regulators and implication in hematological malignancies
- 1 March 2006
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 71 (6) , 713-721
- https://doi.org/10.1016/j.bcp.2005.12.017
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- A BCR–JAK2 fusion gene as the result of a t(9;22)(p24;q11.2) translocation in a patient with a clinically typical chronic myeloid leukemiaGenes, Chromosomes and Cancer, 2005
- The t(8;9)(p22;p24) Is a Recurrent Abnormality in Chronic and Acute Leukemia that Fuses PCM1 to JAK2Cancer Research, 2005
- Computational and Functional Analysis of the Putative SH2 Domain in Janus KinasesBiochemical and Biophysical Research Communications, 2000
- Regulation of the Jak2 Tyrosine Kinase by Its Pseudokinase DomainMolecular and Cellular Biology, 2000
- Janus Kinases and Focal Adhesion Kinases Play in the 4.1 Band: A Superfamily of Band 4.1 Domains Important for Cell Structure and Signal TransductionMolecular Medicine, 1998
- JAKS AND STATS: Biological ImplicationsAnnual Review of Immunology, 1998
- A TEL-JAK2 Fusion Protein with Constitutive Kinase Activity in Human LeukemiaScience, 1997
- Fusion of TEL, the ETS-Variant Gene 6 (ETV6), to the Receptor-Associated Kinase JAK2 as a Result of t(9; 12) in a Lymphoid and t(9; 15; 12) in a Myeloid LeukemiaBlood, 1997
- Oligomerization of the ABL Tyrosine Kinase by the Ets Protein TEL in Human LeukemiaMolecular and Cellular Biology, 1996
- A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins.Molecular and Cellular Biology, 1993